A detailed history of Williams Jones Wealth Management, Llc. transactions in Genmab A/S stock. As of the latest transaction made, Williams Jones Wealth Management, Llc. holds 67,511 shares of GMAB stock, worth $1.37 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
67,511
Previous 83,525 19.17%
Holding current value
$1.37 Million
Previous $2.1 Million 21.59%
% of portfolio
0.02%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$23.84 - $28.48 $381,773 - $456,078
-16,014 Reduced 19.17%
67,511 $1.65 Million
Q2 2024

Aug 05, 2024

SELL
$25.13 - $30.27 $148,518 - $178,895
-5,910 Reduced 6.61%
83,525 $2.1 Million
Q1 2024

May 07, 2024

SELL
$26.43 - $32.77 $1.6 Million - $1.99 Million
-60,702 Reduced 40.43%
89,435 $2.68 Million
Q4 2023

Feb 14, 2024

SELL
$27.94 - $35.44 $206,923 - $262,468
-7,406 Reduced 4.7%
150,137 $4.78 Million
Q3 2023

Nov 14, 2023

SELL
$35.27 - $42.24 $74,067 - $88,704
-2,100 Reduced 1.32%
157,543 $5.56 Million
Q2 2023

Aug 14, 2023

SELL
$37.4 - $42.94 $91,929 - $105,546
-2,458 Reduced 1.52%
159,643 $6.07 Million
Q1 2023

May 15, 2023

SELL
$34.88 - $43.22 $377,471 - $467,726
-10,822 Reduced 6.26%
162,101 $6.12 Million
Q4 2022

Feb 14, 2023

BUY
$33.8 - $47.06 $42,182 - $58,730
1,248 Added 0.73%
172,923 $7.33 Million
Q3 2022

Nov 14, 2022

SELL
$31.52 - $373.61 $370,296 - $4.39 Million
-11,748 Reduced 6.4%
171,675 $5.52 Million
Q2 2022

Aug 15, 2022

SELL
$26.83 - $38.57 $1.93 Million - $2.78 Million
-72,034 Reduced 28.2%
183,423 $5.96 Million
Q1 2022

May 16, 2022

SELL
$30.95 - $39.68 $454,253 - $582,383
-14,677 Reduced 5.43%
255,457 $9.24 Million
Q4 2021

Feb 14, 2022

BUY
$35.87 - $47.12 $1.97 Million - $2.58 Million
54,847 Added 25.48%
270,134 $10.7 Million
Q3 2021

Nov 15, 2021

SELL
$41.55 - $48.72 $47,782 - $56,028
-1,150 Reduced 0.53%
215,287 $9.41 Million
Q2 2021

Aug 16, 2021

BUY
$32.88 - $44.57 $328,306 - $445,031
9,985 Added 4.84%
216,437 $8.84 Million
Q1 2021

May 17, 2021

BUY
$30.92 - $44.4 $645,362 - $926,716
20,872 Added 11.25%
206,452 $6.78 Million
Q4 2020

Feb 16, 2021

BUY
$33.66 - $40.76 $677,575 - $820,498
20,130 Added 12.17%
185,580 $7.55 Million
Q3 2020

Nov 13, 2020

BUY
$33.07 - $38.68 $946,628 - $1.11 Million
28,625 Added 20.92%
165,450 $6.06 Million
Q2 2020

Aug 14, 2020

BUY
$20.05 - $33.89 $303,757 - $513,433
15,150 Added 12.45%
136,825 $4.64 Million
Q1 2020

May 15, 2020

SELL
$17.15 - $25.22 $770,034 - $1.13 Million
-44,900 Reduced 26.95%
121,675 $2.58 Million
Q4 2019

Feb 14, 2020

SELL
$18.88 - $24.14 $20,768 - $26,554
-1,100 Reduced 0.66%
166,575 $3.72 Million
Q3 2019

Nov 14, 2019

BUY
$18.0 - $21.38 $3.02 Million - $3.58 Million
167,675 New
167,675 $3.4 Million

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.4B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Williams Jones Wealth Management, Llc. Portfolio

Follow Williams Jones Wealth Management, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Williams Jones Wealth Management, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Williams Jones Wealth Management, Llc. with notifications on news.